[Comprehensive assessment of bronchial asthma: why it matters?]

Abstract

Assessment of bronchial asthma is essential to optimize management and improve patient outcomes. A personalized, precision medicine approach, guided by comprehensive, accurate, and repeated assessments, is necessary to develop an individualized treatment strategy, to improve asthma control, and to achieve the best possible long-term outcomes, addressing the unique needs of each patient based on their asthma phenotype, endotype, severity, and response to treatment. Recent advances in research and technology have significantly diversified the methods of asthma assessment. Assessments include symptom control, risk factors for acute exacerbations and mortality, type 2 airway inflammation, atopic status and triggers, medication adherence, and comorbidities, providing a solid foundation for accurate disease management. Moreover, the promotion of improving the capability of prevention, diagnosis and treatment of asthma project, affiliated to pulmonary and critical care medicine training program, have provided strong support for enhancing the capability of asthma assessment. In the future, with the ongoing innovation and refinement of assessment techniques, we believe that optimizing comprehensive asthma assessment will definitely improve the rate of good control, even the rate of clinical remission, and ultimately reduce the overall burden of disease.